Rethinking Ligand Efficiency: Normalization Pitfalls, Uncertainty, and State-Invariant Metrics

Hongtao Zhao1

  • 1Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 43183, Sweden.

PubMed